DRUG SAFETY DATA COVERAGE IN MEDICAL LITERATURE

Abstract

The paper discusses whether it is expedient to use the standards approved by the editorial staff of a number of medical journals for original articles on the therapeutic effect of drugs, including antirheumatic agents since this is of importance for the analysis of their safety.

Keywords

• drug safety
• unfavorable event
• standards for reports on clinical trials
• randomized clinical trials
• rheumatoid arthritis.